Commercial TAVR in an Evolving Landscape with Expanded Indications

December 18, 2020

This is video #4 of a 7 part series on Cerebral Embolic Protection for Ischemic Stroke.  Click here to watch the next video. 

With the commercialization of low-risk TAVR treatments, new treatment centers, and increasing TAVR volumes, the TAVR landscape is evolving. Hear Medical Director at UMPC Pinnacle Health and implanting Interventional Cardiologist, Dr. Hemal Gada, discuss the implications of a changing landscape and clinical data considerations around TAVR and TAVR-related stroke.

Login to view comments. Click here to Login